Keld Flintholm Jørgensen
Direktor/Vorstandsmitglied bei SCANDION ONCOLOGY A/S
Profil
Keld Flintholm Jørgensen is currently an Independent Director at Scandion Oncology A since 2022 and a Senior VP & Head-Business Development at H.
Lundbeck A since 2019.
Previously, he worked as a Director-Strategic Partnering at Roche Pharma (Schweiz) AG.
He has an undergraduate and graduate degree from Copenhagen Business School.
Aktive Positionen von Keld Flintholm Jørgensen
Unternehmen | Position | Beginn |
---|---|---|
H. LUNDBECK A/S | Corporate Officer/Principal | 04.04.2019 |
SCANDION ONCOLOGY A/S | Direktor/Vorstandsmitglied | 01.04.2022 |
Ehemalige bekannte Positionen von Keld Flintholm Jørgensen
Unternehmen | Position | Ende |
---|---|---|
Roche Pharma (Schweiz) AG
Roche Pharma (Schweiz) AG Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Pharma (Schweiz) AG is a Swiss pharmaceutical company that develops innovative medicines in key therapeutic areas. The private company is based in Basel, Switzerland. The company translates scientific excellence into advanced medicines that help patients. | Corporate Officer/Principal | - |
Ausbildung von Keld Flintholm Jørgensen
Copenhagen Business School | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
H. LUNDBECK A/S | Health Technology |
SCANDION ONCOLOGY A/S | Health Technology |
Private Unternehmen | 1 |
---|---|
Roche Pharma (Schweiz) AG
Roche Pharma (Schweiz) AG Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Pharma (Schweiz) AG is a Swiss pharmaceutical company that develops innovative medicines in key therapeutic areas. The private company is based in Basel, Switzerland. The company translates scientific excellence into advanced medicines that help patients. | Distribution Services |